Position in CSTL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,157,237
+$706,581 QoQ
Shares Held
47,138
+306.9% QoQ
Ownership
0.155%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 38%
Shared 0%
None 62%
Common Shares in CSTL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Man Group plc holds $418,635,799 across 23 Diagnostics & Research names. CSTL ranks #18 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
1,331,912 | $151,811,328 | |
| 2 | DHR |
Danaher Corp /De/
|
294,073 | $55,756,240 | |
| 3 | NTRA |
Natera, Inc.
|
265,440 | $53,085,345 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
68,272 | $32,783,531 | |
| 5 | LH |
Labcorp Holdings Inc.
|
90,544 | $24,158,043 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
46,402 | $22,807,974 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
34,525 | $19,399,251 | |
| 8 | DGX |
Quest Diagnostics Inc
|
98,184 | $19,242,100 |
All Filings in CSTL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,157,237 | 47,138 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $450,656 | 11,585 | Shares | Defined | 2026-02-17 | |
| 2025-03-31 | $290,570 | 14,514 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $354,498 | 13,302 | Shares | Defined | 2025-02-14 | |
| 2024-06-30 | $208,992 | 9,600 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $510,712 | 23,057 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||